Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. . DSIJ Intelligence-1 / Wednesday, May 7, 2025 / Article rating: 4.4 From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. .
Pharma Penny Stock Under Rs 50 In Green After Signing MoU with Respilon Group s.r.o Pharma Penny Stock Under Rs 50 In Green After Signing MoU with Respilon Group s.r.o From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent. DSIJ Intelligence-1 / Monday, April 28, 2025 / Article rating: 4.0 From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent.
Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It? Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It? From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent. DSIJ Intelligence-1 / Thursday, April 3, 2025 / Article rating: 4.5 From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent.
Pharma Penny Stock Under Rs 50 in Green After Signing an MoU with Indian Navy (INS Kalinga) Pharma Penny Stock Under Rs 50 in Green After Signing an MoU with Indian Navy (INS Kalinga) The company has a market cap of over Rs 1,200 crore and has delivered good profit growth of 25 per cent CAGR over the last 5 years. DSIJ Intelligence-1 / Thursday, March 13, 2025 / Article rating: 3.4 From Rs 34.51 per share (52-week low) to Rs 38.29 per share, the stock is up by 11 per cent.
Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent. DSIJ Intelligence-1 / Wednesday, February 5, 2025 / Article rating: 3.3 From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.
Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent. DSIJ Intelligence-1 / Tuesday, January 28, 2025 / Article rating: 4.2 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23 33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23 From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent. DSIJ Intelligence-1 / Thursday, January 23, 2025 / Article rating: 4.6 From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.
Pharma Penny Stock Under Rs 60 Jumps After Reporting a 33 Per Cent Jump In PAT Pharma Penny Stock Under Rs 60 Jumps After Reporting a 33 Per Cent Jump In PAT From Rs 43.42 per share (52-week low) to Rs 55.66 per share, the stock is up by 28.2 per cent. DSIJ Intelligence-1 / Monday, January 20, 2025 / Article rating: 3.0 From Rs 43.42 per share (52-week low) to Rs 55.66 per share, the stock is up by 28.2 per cent.
Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent. DSIJ Intelligence-1 / Wednesday, January 8, 2025 / Article rating: 4.0 From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
Pharma Penny Stock Under Rs 60 in Green After Credit Rating Update; Details Inside Pharma Penny Stock Under Rs 60 in Green After Credit Rating Update; Details Inside From Rs 43.42 per share (52-week low) to Rs 51.49 per share, the stock is up by 18.60 per cent. DSIJ Intelligence-1 / Friday, January 3, 2025 / Article rating: 3.9 From Rs 43.42 per share (52-week low) to Rs 51.49 per share, the stock is up by 18.60 per cent.